Highlights SANA AB

Equities

SANION

SE0005794617

Market Closed - Nasdaq Stockholm Other stock markets 11:29:55 2024-06-04 am EDT			5-day change	1st Jan Change
2.475 ^SEK	-1.20%		+22.52%	-38.28%

May. 29	Saniona AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 08	Terna in first quarter increases profit and revenues by double digits	AN

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Saniona AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 29	CI
Terna in first quarter increases profit and revenues by double digits	May. 08	AN
Saniona AB Reports Progress on Pipeline and Other Activities	May. 07	CI
Imprendiroma, indicators increase to triple digits in 2023	Apr. 30	AN
BasicNet, revenues fall in first quarter; Ebitda down double digits	Apr. 30	AN
Digital Value in 2023 increases revenues by 20 percent; up profit	Apr. 30	AN
Sana Biotechnology Shares Rise as Q4 Non-GAAP Net Loss Narrows	Mar. 01	MT
Sana Biotechnology Q4 Non-GAAP Net Loss Narrows; Cash, Cash Equivalents Decline	Feb. 29	MT
Saniona AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Saniona AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Israeli missile attack hits high-security district in Syrian capital	Feb. 21	RE
Saniona Announces the Selection of Its Proprietary GABAA A5 Negative Allosteric Modulator Lead Compound, San2465	Jan. 02	CI
Saniona AB Strengthens Epilepsy Pipeline with Selection of SAN2355 as Clinical Candidate	Dec. 27	CI
Saniona and Boehringer Ingelheim Extend Research Term with Up to Two Years	Dec. 18	CI
Saniona AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 30	CI
Saniona Promotes Kv7 Epilepsy Compound to Candidate Selection Phase	Nov. 21	CI
Saniona Announces Positive Preclinical Data on Saniona's SAN711 in Epilepsy Presented at SfN	23-10-27	CI
Saniona AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-31	CI
Saniona, AstronauTx Partner on Study of Alzheimer's, Neurodegenerative Conditions	23-07-18	MT
Saniona Enters into Collaboration Agreement with Astronautx in Alzheimer's Disease	23-07-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights SANA AB

Equities

SANION

SE0005794617

Highlights

Filters